General description
INN
Bortezomib
ATC codes
Medicine type
Chemical agent
EML status history
First added in 2019
(TRS
1021)
for
Plasma cell myeloma
Wikipedia
DrugBank
Recommendations
Section
Targeted therapies
- Parenteral > General injections > unspecified: 3.5 mg in vial powder for injection
Indications